Swedish University Hospital applies brain segmentation software from SyntheticMR in Multiple Sclerosis research

SyntheticMR AB, a subsidiary of Accelerator Nordic AB, and Örebro University Hospital has entered into a collaboration agreement regarding the use of SyntheticMR’s software SyMRI® Diagnostics in research on Multiple Sclerosis (MS).

Örebro University Hospital will use SyMRI Diagnostics in a research project aiming to assess MS using conventional and Synthetic MRI images, identify MS lesions based on tissue characteristics and evaluate the correlation between clinical symptoms and brain tissue changes as measured with the SyMRI software.

“One possible advantage with Synthetic MRI is a shortening of study time as only one series of images is needed to obtain the required type of images. Another interesting potential with Synthetic MRI is that tissue characteristics, which are used to create contrast in MR images, are determined through a quantitative method. We aim to evaluate these possibilities”, comments Wolfgang Krauss, MD at Örebro University Hospital, as motivation for using SyMRI. Wolfgang Krauss will lead the research project under the supervision of Per Thunberg, Associate Professor and PhD.

“We are looking forward to collaborating with Örebro University Hospital on this project and have high expectations on the outcome, which is important for us in order to make sure that we develop software that is optimized for both research and clinical needs”, says Marcel Warntjes, CEO of SyntheticMR.

For additional information please contact Andreas Bunge, CEO of Accelerator Nordic AB, +46 70 824 25 25.

Accelerator Nordic AB is a group of Life Science companies focused on pharmaceutical drug development and medical devices. Accelerator’s subsidiaries have exposure towards large growth markets such as cancer therapy, medical imaging and orthopedics. The first medical device products are now on the market and a combination product is in clinical phase. The business model is centered on partnering or out-licensing. Accelerator Nordic is publicly traded on the Aktietorget exchange in Stockholm, Sweden. For more information please visit, www.acceleratorab.se.

SyntheticMR AB, a subsidiary to Accelerator Nordic AB, has developed SyMRI Diagnostics, software for more effective Magnetic Resonance Imaging. SyMRI Diagnostics uses a rapid MRI scan that provides a measure for patient tissue properties. Using these properties conventional MRI images and tissue images can be generated. In this way examination time is reduced for the patient and the decision support is improved for the radiologist. For more information, please visit www.syntheticmr.se.